Shares of Cellcom Israel, Ltd. (NYSE:CEL) have earned a consensus broker rating score of 5.00 (Strong Sell) from the one brokers that provide coverage for the company, Zacks Investment Research reports. One analyst has rated the stock with a strong sell rating.

Zacks has also assigned Cellcom Israel an industry rank of 210 out of 265 based on the ratings given to related companies.

Separately, BidaskClub downgraded Cellcom Israel from a “sell” rating to a “strong sell” rating in a research report on Saturday, August 26th.

Shares of Cellcom Israel (NYSE:CEL) opened at $9.78 on Wednesday. The company has a debt-to-equity ratio of 1.97, a current ratio of 1.44 and a quick ratio of 1.41. Cellcom Israel has a 12-month low of $7.74 and a 12-month high of $11.19. The stock has a market capitalization of $995.99, a price-to-earnings ratio of 30.94 and a beta of 2.08.

A number of institutional investors have recently added to or reduced their stakes in CEL. Sphera Funds Management LTD. acquired a new position in Cellcom Israel in the third quarter valued at $14,301,000. Vanguard Group Inc. increased its stake in Cellcom Israel by 8.7% in the second quarter. Vanguard Group Inc. now owns 1,016,527 shares of the technology company’s stock valued at $9,800,000 after purchasing an additional 81,105 shares during the last quarter. Bank of America Corp DE increased its stake in Cellcom Israel by 153.2% in the first quarter. Bank of America Corp DE now owns 47,781 shares of the technology company’s stock valued at $492,000 after purchasing an additional 28,910 shares during the last quarter. Credit Suisse AG increased its stake in Cellcom Israel by 61.6% in the first quarter. Credit Suisse AG now owns 61,754 shares of the technology company’s stock valued at $635,000 after purchasing an additional 23,544 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in Cellcom Israel by 4.1% in the second quarter. Dimensional Fund Advisors LP now owns 78,732 shares of the technology company’s stock valued at $759,000 after purchasing an additional 3,102 shares during the last quarter. Hedge funds and other institutional investors own 6.97% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This story was first reported by American Banking News and is the property of of American Banking News. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this story can be viewed at https://www.americanbankingnews.com/2017/12/13/zacks-cellcom-israel-ltd-cel-given-consensus-recommendation-of-strong-sell-by-analysts.html.

Cellcom Israel Company Profile

Cellcom Israel Ltd. is engaged in the provision of cellular telephone services. The Company offers fixed-line services. The Company operates in two segments: Cellular and Fixed-line. The cellular segment includes the cellular communications services, end user cellular equipment and supplemental services.

Get a free copy of the Zacks research report on Cellcom Israel (CEL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Cellcom Israel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellcom Israel and related companies with MarketBeat.com's FREE daily email newsletter.